Metastatic Breast Cancer Clinical Trials
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
E
W
Recruiting
- Metastatic Breast Cancer
- Leptomeningeal Disease
- High-dose Methotrexate (8 gm/m2; HD-MTX)
- Baltimore, Maryland
- +2 more
2022-04-06
Apr 6, 2022T
Recruiting
- Advanced Breast Cancer
- Metastatic Breast Cancer
- Tianjin, Tianjin, ChinaBreast Oncology, Tianjin Medical University Cancer Institute and
2022-04-06
Apr 6, 2022E
A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer
Recruiting
- Breast Cancer
- +3 more
- LY3484356
- +6 more
- Gilbert, Arizona
- +77 more
2022-04-06
Apr 6, 2022N
Recruiting
- Advanced Breast Cancer
- +7 more
- Anaheim, California
- +4 more
2022-04-06
Apr 6, 2022U
Not yet recruiting
- Metastatic Breast Cancer
- DOULA-AC 1
- Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
2022-03-28
Mar 28, 2022A
Recruiting
- Metastatic Breast Cancer
- Trastuzumab deruxtecan
- +6 more
- Iowa City, Iowa
- +57 more
2022-04-05
Apr 5, 2022U
Recruiting
- Breast Cancer
- +2 more
- Madison, WisconsinUniversity of Wisconsin School of Medicine and Public Health
2022-04-04
Apr 4, 2022N
Not yet recruiting
- Metastatic Breast Cancer
- Ribociclib
- +5 more
- (no location specified)
2022-04-04
Apr 4, 2022E
Available
- Metastatic Breast Cancer
- Liverpool, New South Wales, Australia
- +229 more
2022-04-05
Apr 5, 2022H
Recruiting
- Metastatic Breast Cancer
- Trastuzumab Emtansine
- +2 more
- Fountain Valley, California
- +133 more
2022-04-04
Apr 4, 2022S
Recruiting
- Metastatic Breast Cancer
- +2 more
- Denosumab (reduced dosing)
- Denosumab (standard dosing)
- Feldkirch, Austria
- +49 more
2022-04-04
Apr 4, 2022V
Not yet recruiting
- Metastatic Breast Cancer
- Enobosarm & Abemaciclib Combo
- non-steroidal AI, or steroidal AI (exemestane with or without everolimus) or Fulvestrant
- Chandler, Arizona
- +15 more
2022-04-01
Apr 1, 2022V
Recruiting
- Metastatic Breast Cancer
- Anchorage, Alaska
- +50 more
2022-04-01
Apr 1, 2022V
Not yet recruiting
- Metastatic Breast Cancer
- Sabizabulin
- Exemestane monotherapy, exemestane plus everolimus, or selective estrogen receptor modulator
- Anchorage, Alaska
- +25 more
2022-04-01
Apr 1, 2022S
Recruiting
- Metastatic Breast Cancer
- Ribociclib + Letrozole OR Fulvestrant
- +2 more
- Creixomil, Portugal
- +44 more
2022-04-01
Apr 1, 2022U
Recruiting
- Metastatic Breast Cancer
- +2 more
- Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
2022-03-31
Mar 31, 2022A
Active, not recruiting
- Metastatic Breast Cancer
- Veliparib Placebo
- +3 more
- Gilbert, Arizona
- +218 more
2022-03-11
Mar 11, 2022C
Not yet recruiting
- Breast Neoplasms
- +3 more
- surgical treatment 1
- +2 more
- (no location specified)
2022-03-20
Mar 20, 2022M
Completed
- Metastatic Breast Cancer
- Nurse AMIE (Addressing Metastatic Individuals Every day)
- Hershey, PennsylvaniaHershey Medical Center
2022-03-31
Mar 31, 2022O
Active, not recruiting
- Metastatic Breast Cancer
- Recurrent Breast Cancer
- Taselisib
- +4 more
- Boston, Massachusetts
- +2 more
2022-03-21
Mar 21, 2022A
Recruiting
- Metastatic Breast Cancer
- None (Observational study)
- Macquarie, New South Wales, Australia
- +42 more
2022-03-17
Mar 17, 2022A
Recruiting
- Invasive Breast Cancer
- +3 more
- Pembrolizumab
- Sacituzumab Govitecan
- Atlanta, Georgia
- +5 more
2022-03-30
Mar 30, 2022C
Not yet recruiting
- Breast Cancer
- Metastatic Breast Cancer
- Blood sampling
- Caen, FranceCentre François Baclesse
2022-03-21
Mar 21, 2022U
Recruiting
- Breast Cancer
- +2 more
- Monza, Italy
- +2 more
2022-03-29
Mar 29, 2022